← Open Payments lookup

RYAN PAVELKA: Open Payments

NPI 1134875578 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,613 in 90 payments from 15 companies in 2025. Trend: 2023 $537 · 2024 $843 · 2025 $1,613

Food & beverage: $1,613
CompanyPaymentsAmount
Novo Nordisk Inc19$294
Lilly USA, LLC17$266
PFIZER INC.13$227
Axsome Therapeutics, Inc.5$154
ABBVIE INC.7$122
Abbott Laboratories5$115
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$87
Amgen Inc.4$65
Sumitomo Pharma America, Inc.1$51
AstraZeneca Pharmaceuticals LP3$48

Products named: MOUNJARO, Auvelity, Wegovy, Ozempic, PREVNAR 20, FREESTYLE LIBRE 3, NURTEC ODT, XIFAXAN.

Industry payments across TX — which companies pay providers there.